LabCompass

Amy L. Dunn

Medicine · The Ohio State University

Established · publishing since 1998Rising activity

Publications

174

Citations

2,740

Est. group size

~2

Recurring co-author estimate

Active years

29

Publishing since 1998

Research summary
AI-generated

Amy L. Dunn's research focuses on inherited bleeding disorders, particularly hemophilia A and B and von Willebrand disease, with an emphasis on clinical trials of new treatments including gene therapy, factor replacement therapies, and prophylactic drug regimens. Her work often involves large multinational clinical trials evaluating safety, efficacy, and quality-of-life outcomes for children and adults with these conditions, as well as developing clinical practice guidelines and imaging protocols for monitoring joint health in hemophilia patients.

Hemophilia A and B treatmentVon Willebrand diseaseGene therapy for bleeding disordersClinical trials and prophylaxis regimensMusculoskeletal imaging in hemophilic arthropathy

Publication output has fluctuated over the last decade, with a notable peak in 2023, but appears to be tapering off in 2025 and 2026 (partial-year data).

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 10.2/year recently
2017: 12 publications172018: 17 publications182019: 8 publications192020: 11 publications202021: 10 publications212022: 9 publications222023: 20 publications20232024: 12 publications242025: 7 publications252026: 3 publications26
Recent publications
Publishes in
  • Haemophilia×20
  • Blood×19
  • Research and Practice in Thrombosis and Haemostasis×12
  • Elsevier eBooks×10
  • Journal of Thrombosis and Haemostasis×8
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile